These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11836319)

  • 21. [Epidemiological study of clinical characteristics of Chinese Han ethnic women with polycystic ovary syndrome].
    Zhao JL; Chen ZJ; Zhao LX; Geng L; Wang S; Gao SS; Zhang P; Liu S; Zhou FR
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):375-9. PubMed ID: 16831357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.
    Orio F; Matarese G; Di Biase S; Palomba S; Labella D; Sanna V; Savastano S; Zullo F; Colao A; Lombardi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5887-92. PubMed ID: 14671186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.
    Echiburú B; Pérez-Bravo F; Maliqueo M; Sánchez F; Crisosto N; Sir-Petermann T
    Metabolism; 2008 Dec; 57(12):1765-71. PubMed ID: 19013303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
    Legro RS; Finegood D; Dunaif A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic determinants of insulin action in polycystic ovary syndrome.
    Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPARgamma gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men.
    Kahara T; Takamura T; Hayakawa T; Nagai Y; Yamaguchi H; Katsuki T; Katsuki K; Katsuki M; Kobayashi K
    Metabolism; 2003 Feb; 52(2):209-12. PubMed ID: 12601634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum visfatin in Asian women with polycystic ovary syndrome.
    Jongwutiwes T; Lertvikool S; Leelaphiwat S; Rattanasiri S; Jultanmas R; Weerakiet S
    Gynecol Endocrinol; 2009 Aug; 25(8):536-42. PubMed ID: 19533482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome].
    Chen ZJ; Shi YH; Zhao YR; Li Y; Tang R; Zhao LX; Chang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):582-5. PubMed ID: 15498182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism.
    Lin TC; Yen JM; Gong KB; Kuo TC; Ku DC; Liang SF; Wu MJ
    BMC Med Genet; 2006 Apr; 7():36. PubMed ID: 16603055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance.
    Saxena R; Georgopoulos NA; Braaten TJ; Bjonnes AC; Koika V; Panidis D; Welt CK
    Hum Reprod; 2015 Jun; 30(6):1454-9. PubMed ID: 25904635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
    Ehrmann DA; Schneider DJ; Sobel BE; Cavaghan MK; Imperial J; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2108-16. PubMed ID: 9215280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome.
    Pappalardo MA; Vita R; Di Bari F; Le Donne M; Trimarchi F; Benvenga S
    J Endocrinol Invest; 2017 Apr; 40(4):367-376. PubMed ID: 27785750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovary syndrome and abnormalities in glucose tolerance.
    Bhattacharya SM
    Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and ethnic differences in the metabolic response of polycystic ovary syndrome.
    Ezeh U; Ida Chen YD; Azziz R
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):163-172. PubMed ID: 32286715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study.
    Palep-Singh M; Picton HM; Yates ZR; Barth J; Balen AH
    Hum Fertil (Camb); 2007 Mar; 10(1):33-41. PubMed ID: 17454207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.